Skip to main content
Search

AstraZeneca posts robust results amid Chinese import tax allegations

Date: 06 February 2025

1 minute read

6 February 2025

If you are covering AstraZeneca's latest results, please see the following comment from Sheena Berry, healthcare analyst at Quilter Cheviot:
 
"AstraZeneca posted a robust set of results this morning, with Q4 total revenue up 25% and earnings per share up 49% - both ahead of expectations. The company’s oncology franchise has also continued with strength, delivering double digit growth of 29% in Q4.
 
"China has proven to be an overhang on the stock following the fraud investigations of several individuals, and questions remain on exactly what impact this might have on operations in China. Sales declined 3% in the region, largely as a result of lower rates of seasonal respiratory viral infections and tightening hospital budgets. While the import tax allegation is certainly a headline generating blemish on the company, it appears manageable.
 
"Looking ahead, 2025 guidance implies another year of solid growth is anticipated by management. AstraZeneca is guiding to high single digit total revenue growth in 2025, with earnings per share expected to increase to low double digits. 2025 is expected to be a catalyst rich year, and this should help provide investors with confidence in the group’s $80bn revenue ambition in 2030."

Megan Southwell

External Communications Manager
+44 (0)7500 523227

Notes to Editors

Notes to Editors:

About Quilter plc

Quilter plc is a leading wealth management business, helping to create brighter financial futures for every generation.

Quilter plc oversees £157.4 billion in customer investments (as at 30 June 2026).

It has an adviser and customer offering spanning financial advice, investment platforms, multi-asset investment solutions and discretionary fund management.

The business is comprised of two branded segments: Quilter and Quilter Cheviot.

Quilter encompasses the financial advice network and national, Quilter's investment platform and multi-asset solutions and Quilter Invest, the digital savings and investment app.

Quilter Cheviot is a discretionary fund management and financial planning business.

This press release is for journalists only and should not be relied upon by financial advisers or customers.

Please remember that past performance is not a guide to future performance. The value of investments and the income from them can go down as well as up and investors may not get back any of the amount originally invested. Exchange rate changes may cause the value of overseas investments to rise or fall.

This communication is issued by Quilter plc.  Registered office: Senator House, 85 Queen Victoria Street, London, EC4V 4AB, United Kingdom. Registered number: 6404270.  Registered in England.

PRIVACY INFORMATION
We hold your name, email address, job role and the name of your publication on our Press Distribution List and use this information to send you press releases which we believe will be of interest to you. You can stop receiving emails from us at any time by emailing us at: pressoffice@quilter.com and asking us to remove you from the Distribution List.

Related Articles

BP agrees to sell majority stake in Castrol to pay down debt

2 minute read

If you are covering the news that BP will sell its majority stake in Castrol to Stonepeak, please see the following comment from Maurizio Carulli, global energy and materials analyst at Quilter Cheviot:

Published 24 December 2025

US inflation comes in cooler than expected as focus on Fed independence grows

1 minute read

If you are covering the latest US inflation data, please see the following comment from Richard Carter, head of fixed interest research at Quilter Cheviot:

Published 18 December 2025